The potential role of adiponectin in diagnostics is associated with protection against atherogenesis, insulin resistance, and obesity and as a possible marker of risk for developing menopausal metabolic syndrome [4–11]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.